The report is the preliminary toxicology information for dibromophenyl glycidyl ether. As required by 40 CFR 716, we herewith submit copies of reports which meet the requirements of the referenced rule as Health and Safety Studies. As noted in the statement enclosed with the reports, some contain confidential business information. The reports are separated into three categories for your convenience. Package 1. Reports which contain no Confidential Business Information. Package 2. Reports which contain Confidential Business Information. Package 3. Reports from which Confidential Business Information has been deleted. (Public File Copy of reports in Package 2). Each report is marked with an identifying number at the top of the first page of the report, e.g., D-155. Use of this identification number in future correspondence regarding this submission will facilitate handling of questions.